Releases
Found 35204 articles
West Monroe Named a Notable Provider in Forrester Risk Consulting Report
Chicago-based consulting firm West Monroe has earned recognition as a Notable Provider in Forrester's Q3 2026 Risk Consulting Services Landscape. The report highlights the firm's industry-first approach, which integrates risk expertise directly into core business and technology functions rather than treating it as a standalone operational silo.
Rockpoint and Newbond Acquire Hotel Maren Fort Lauderdale
A prime stretch of Florida coastline has changed hands as Boston-based Rockpoint and Newbond Holdings finalize their purchase of the Hotel Maren Fort Lauderdale. The deal marks the latest collaboration between the two investment firms, following their joint acquisition of the Westin Tampa Waterside just one year ago.
Stellar Cyber Earns Progressive Company Status in NDR Market Analysis
MarketsandMarkets has designated Stellar Cyber a Progressive Company within its 360Quadrant for Network Detection and Response. The recognition highlights the firm’s technical footprint in AI-driven threat analysis and its success in integrating network visibility across increasingly complex, distributed IT, OT, and cloud environments.
Hall Render Expands St. Louis Footprint with Two New Shareholders
Barely a month after establishing its physical presence in Missouri, national law firm Hall Render has recruited Elizabeth Tucker and Brett Travers as shareholders. The move signals an aggressive strategy to capture the growing demand for specialized legal counsel within the regional health care and senior living sectors.
FirstEnergy Foundation Pledges $1.2 Million to Combat Pennsylvania Hunger
The FirstEnergy Foundation is channeling $1.2 million into 37 Pennsylvania food banks and pantries this September, aiming to supply 3.6 million meals. The initiative, launched during Hunger Action Month, addresses a persistent regional crisis where an estimated 1.8 million residents struggled with food access as of 2024.
Cellipont Bioservices Advances Six Cell Therapy Projects Toward 2026 INDs
Six distinct cell therapy programs currently under development at Cellipont Bioservices’ Texas facility are slated for Investigational New Drug application submissions within 2026. This milestone highlights the contract manufacturer’s capacity to shepherd multiple complex therapeutic pipelines simultaneously through rigorous process optimization and regulatory preparation stages.
Ohio Lottery Integrates Retail and Digital Play via Scratch Connect
Nearly 570,000 Ohio players have engaged with the lottery’s new Scratch Connect platform, bridging physical tickets with mobile gaming. Data from Scientific Games shows that 90% of those who scanned their $5 Bonus Cash Wheel tickets completed the digital bonus game, with 40% immediately opting to play again.
Cypress Creek Energy Opens 104 MW Ostrea Solar Farm in Washington
Cypress Creek Energy has officially launched its 104 MWdc Ostrea Solar project in Yakima County, marking a $180 million boost to Washington’s energy infrastructure. The facility, which provides power to Microsoft, coincides with the state’s rapid economic expansion and highlights a shift toward integrating large-scale renewables with local habitat conservation.
SwitchBot Debuts Retrofit Smart Lock Combo at IFA 2026
At IFA 2026 in Berlin, SwitchBot introduced its Lock Ultra Max Vision Pro Combo, a retrofit smart-entry system tailored for European households. The package integrates a high-speed motorized lock with advanced biometric security, allowing users to upgrade their existing door hardware without replacing cylinders or modifying door structures.
River Associates Exits Trident Solutions in Deal with Align Capital
The Chattanooga-based private equity firm River Associates finalized the sale of Plano-based Trident Solutions to Align Capital Partners on August 31, 2026. This transaction marks the firm’s third exit of the year, concluding a period of significant consolidation and growth for the safety marking and infrastructure provider.
ASPCA Names 2026 Humane Award Honorees
From a search-and-rescue dog deployed to disaster zones to a therapy miniature horse duo navigating hospital halls, the ASPCA has selected its 2026 Humane Award recipients. These annual honors recognize both human and animal advocates whose work has redefined the bond between species and improved welfare standards nationwide.
Global Radiation Dose Management Market Expected to Reach $960 Million
The global market for radiation dose management systems is set to grow from $510 million in 2026 to $960 million by 2031. Driven by a 13.3% compound annual growth rate, the sector is expanding as healthcare providers increasingly adopt automated monitoring and data-driven quality assurance tools to optimize patient safety.
Osteosarcoma Market Poised for Growth as Eight Therapies Enter Pipeline
The global osteosarcoma market, valued at approximately USD 60 million in 2025, is projected to grow at a 9% CAGR through 2036. This expansion is fueled by a diversifying pipeline of targeted therapies and immunotherapeutic agents aimed at addressing the significant clinical needs of patients with relapsed or metastatic disease.
T. Rowe Price Launches Securitized Income ETF to Diversify Fixed Income
T. Rowe Price has expanded its active exchange-traded fund lineup to 35 offerings with the launch of the Securitized Income ETF. Trading under the ticker TSCZ on the NYSE Arca, the fund targets higher current income by investing in asset-backed, mortgage-backed, and collateralized loan obligations for a 0.20% expense ratio.
AKKO Expands Beyond Keyboards with New Gaming Lineup at IFA 2026
Marking a decade of growth, AKKO is pivoting from its roots in mechanical keyboards to a full-scale gaming ecosystem. At IFA 2026 in Berlin, the brand is debuting a series of carbon-fiber mice, high-fidelity headsets, and specialized arcade controllers, signaling a push into competitive hardware across the European market.
MANGOAL Targets Factory-Fit Dash Cam Integration for Mainstream Vehicles
With over one million units sold globally, Shenzhen-based MANGOAL has carved a niche in the automotive electronics market by replacing bulky aftermarket dash cams with discreet, factory-fit hardware. The company leverages more than 900 custom molds to ensure its recording systems blend seamlessly into the existing interiors of mainstream vehicles.
Pomerantz LLP Probes L3Harris Following CEO Departure
A 4.61% drop in L3Harris Technologies stock followed the abrupt resignation of Chairman and CEO Christopher Kubasik on August 17, 2026. The sudden leadership vacuum, triggered by revelations of conduct inconsistent with company values, has now prompted the Pomerantz Law Firm to launch an investigation into potential securities fraud.
Aramco and Quantinuum Partner to Explore Industrial Quantum Computing
Saudi energy giant Aramco and quantum developer Quantinuum have signed a non-binding memorandum of understanding to test whether quantum systems can solve complex industrial challenges. The collaboration focuses on preparing for fault-tolerant computing, specifically targeting digital transformation and scientific research within the global energy sector.
Pomerantz Law Firm Launches Securities Investigation into Qfin Holdings
A sharp 18.91% slide in Qfin Holdings’ share price following dismal second-quarter results has triggered a formal investigation by Pomerantz LLP. The firm is scrutinizing whether company leadership misled shareholders regarding financial health, as the business grapples with plummeting revenues and unexpected tax liabilities in the Chinese consumer credit market.
Pomerantz LLP Launches Investigation into Azenta Following CEO Resignation
A 12% drop in Azenta’s stock price has triggered a formal investigation by Pomerantz LLP, as the law firm examines potential securities fraud following the abrupt departure of CEO John Marotta. The firm is now soliciting contact from shareholders to determine if company leadership engaged in unlawful business practices.
Pomerantz LLP Launches Investigation Into Sionna Therapeutics
Sionna Therapeutics faces a potential class action investigation after the company’s stock plummeted more than 91% in a single day. The inquiry, led by Pomerantz LLP, centers on whether executives misled shareholders regarding the clinical efficacy of its lead nucleotide binding domain stabilizer programs.
Pomerantz LLP Probes Sellas Life Sciences Following Clinical Trial Delay
A 13.15% drop in Sellas Life Sciences stock followed reports that the company failed to disclose results from its phase 3 clinical trial for Galinpepimut-S. The decline occurred after the study reached its 80th patient death, a pre-specified milestone that should have triggered an immediate public release of findings.
Pomerantz LLP Launches OSI Systems Securities Investigation
A 5.21 percent single-day stock decline has triggered a formal investigation into OSI Systems, Inc. by Pomerantz LLP. The inquiry follows an August 20, 2026, earnings report in which the company failed to meet revenue expectations, citing site-related delivery constraints as the primary driver for the shortfall.
Pomerantz LLP Initiates Class Action Against Babcock & Wilcox
Investors who acquired Babcock & Wilcox Enterprises, Inc. securities between November 5, 2025, and March 11, 2026, are being urged to contact legal counsel. Pomerantz LLP has filed a class action lawsuit alleging misconduct, targeting potential financial losses incurred by shareholders during this specific four-month window of market activity.
Pomerantz LLP Launches Investigation Into Abeona Therapeutics
A 15% slide in Abeona Therapeutics stock has triggered a formal investigation by the New York-based Pomerantz LLP. The firm is currently probing whether the company or its leadership committed securities fraud following disclosures regarding revenue recognition issues related to its therapy, ZEVASKYN.
Pomerantz Law Firm Launches Inquiry Into Bally’s Corporation
A 26.3% plunge in Bally’s Corporation stock following a liquidity warning has triggered a formal investigation by Pomerantz LLP. The legal firm is currently examining whether the company’s leadership and directors misled shareholders or engaged in unlawful business practices regarding the firm's financial stability and debt obligations.
Pomerantz LLP Launches Investigation Into EyePoint Following Clinical Trial Miss
Shares of EyePoint Pharmaceuticals plummeted 67% on August 17 after the company reported that its pivotal Phase 3 trial for the wet age-related macular degeneration treatment DURAVYU failed to meet key visual acuity benchmarks when measured against the industry-standard drug Eylea.
Pomerantz Law Firm Probes LENZ Therapeutics Over Financial Disclosures
Pomerantz LLP has launched an investigation into LENZ Therapeutics following a sharp decline in the company’s stock price. The inquiry focuses on potential securities fraud or unlawful business practices, specifically examining whether leadership misled shareholders regarding the commercial performance of their flagship eye drop product, VIZZ.
Pomerantz LLP Launches Investigation Into Hims & Hers Health Practices
The New York-based Pomerantz LLP is probing Hims & Hers Health, Inc. following a series of regulatory challenges and internal disputes that triggered significant stock volatility. The investigation focuses on potential securities fraud, centering on how the company handles sensitive patient data and manages its subscription billing operations.
In-Building Wireless Market Projected to Hit $48.52 Billion by 2032
The global in-building wireless market is poised for significant expansion, with forecasts indicating a climb from $25.37 billion in 2026 to $48.52 billion by 2032. Driven by the rapid rollout of 5G and rising demand for reliable indoor connectivity, the sector is expected to maintain a steady compound annual growth rate of 11.4%.